Nobuhiko Yamauchi

The Cancer Institute Hospital

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Medical Science Medical Science professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Collaborators (5)

Hiromichi Matsushita

Professor

Keio University School of Medicine

JAPAN

View details

Masamitsu Yanada

Nagoya University Hospital

JAPAN

View details

Sumito Shingaki

New York University

UNITED STATES

View details

JUNYA KURODA

Professor

Kyoto Prefectural University of Medicine

JAPAN

View details

Yuji Oshikawa-Kumade

Otsuka Pharmaceutical

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Nobuhiko Yamauchi

Research Interests

Explore related searches

Contact this professor

Articles (10)

Progression-free survival: a true endpoint in first-line treatment for classic Hodgkin Lymphoma?

Impact of <i>NRAS</i> mutation on efficacy of triplet induction therapy in newly diagnosed multiple myeloma

Current treatment approach and future perspectives in B cell lymphoma.

Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study.

Isatuximab plus carfilzomib-dexamethasone for relapsed multiple myeloma.

Current development of chimeric antigen receptor T‐cell therapy for diffuse large B‐cell lymphoma and high‐grade B‐cell lymphoma

Complex karyotype determined using conventional cytogenetic analysis is a poor prognostic factor in patients with multiple myeloma

Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01

Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105)

Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies

Collaborators (5)

Hiromichi Matsushita

Masamitsu Yanada

Sumito Shingaki

JUNYA KURODA

Yuji Oshikawa-Kumade

Make your next move.

Nobuhiko Yamauchi

Research Interests

Explore related searches

Contact this professor

Articles (10)

Progression-free survival: a true endpoint in first-line treatment for classic Hodgkin Lymphoma?

Impact of &lt;i&gt;NRAS&lt;/i&gt; mutation on efficacy of triplet induction therapy in newly diagnosed multiple myeloma

Current treatment approach and future perspectives in B cell lymphoma.

Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study.

Isatuximab plus carfilzomib-dexamethasone for relapsed multiple myeloma.

Current development of chimeric antigen receptor T‐cell therapy for diffuse large B‐cell lymphoma and high‐grade B‐cell lymphoma

Complex karyotype determined using conventional cytogenetic analysis is a poor prognostic factor in patients with multiple myeloma

Clinical utility of genomic profiling of AML using paraffin-embedded bone marrow clots: HM-SCREEN-Japan 01

Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105)

Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies

Collaborators (5)

Hiromichi Matsushita

Masamitsu Yanada

Sumito Shingaki

JUNYA KURODA

Yuji Oshikawa-Kumade

Make your next move.

Impact of <i>NRAS</i> mutation on efficacy of triplet induction therapy in newly diagnosed multiple myeloma